nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—Non-Nucleoside Reverse Transcriptase Inhibitors—Delavirdine—acquired immunodeficiency syndrome	0.142	0.212	CiPCiCtD
Etravirine—Non-Nucleoside Analog—Delavirdine—acquired immunodeficiency syndrome	0.142	0.212	CiPCiCtD
Etravirine—Non-Nucleoside Reverse Transcriptase Inhibitors—Nevirapine—acquired immunodeficiency syndrome	0.108	0.16	CiPCiCtD
Etravirine—Non-Nucleoside Analog—Nevirapine—acquired immunodeficiency syndrome	0.108	0.16	CiPCiCtD
Etravirine—Non-Nucleoside Analog—Efavirenz—acquired immunodeficiency syndrome	0.0861	0.128	CiPCiCtD
Etravirine—Non-Nucleoside Reverse Transcriptase Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.0861	0.128	CiPCiCtD
Etravirine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0105	0.0455	CbGbCtD
Etravirine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00983	0.0428	CbGbCtD
Etravirine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00889	0.0387	CbGbCtD
Etravirine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00889	0.0387	CbGbCtD
Etravirine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00869	0.0379	CbGbCtD
Etravirine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00817	0.0356	CbGbCtD
Etravirine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00817	0.0356	CbGbCtD
Etravirine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00793	0.0345	CbGbCtD
Etravirine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00767	0.0334	CbGbCtD
Etravirine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00745	0.0324	CbGbCtD
Etravirine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00739	0.0322	CbGbCtD
Etravirine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00739	0.0322	CbGbCtD
Etravirine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00717	0.0312	CbGbCtD
Etravirine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00673	0.0293	CbGbCtD
Etravirine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00673	0.0293	CbGbCtD
Etravirine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00646	0.0281	CbGbCtD
Etravirine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00638	0.0278	CbGbCtD
Etravirine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00619	0.027	CbGbCtD
Etravirine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00619	0.027	CbGbCtD
Etravirine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00601	0.0262	CbGbCtD
Etravirine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0056	0.0244	CbGbCtD
Etravirine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0056	0.0244	CbGbCtD
Etravirine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00543	0.0237	CbGbCtD
Etravirine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00543	0.0237	CbGbCtD
Etravirine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00537	0.0234	CbGbCtD
Etravirine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00521	0.0227	CbGbCtD
Etravirine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00505	0.022	CbGbCtD
Etravirine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00475	0.0207	CbGbCtD
Etravirine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00475	0.0207	CbGbCtD
Etravirine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0043	0.0187	CbGbCtD
Etravirine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0043	0.0187	CbGbCtD
Etravirine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00403	0.0176	CbGbCtD
Etravirine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00371	0.0162	CbGbCtD
Etravirine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0036	0.0157	CbGbCtD
Etravirine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00326	0.0142	CbGbCtD
Etravirine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00326	0.0142	CbGbCtD
Etravirine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00312	0.0136	CbGbCtD
Etravirine—ABCB4—blood—acquired immunodeficiency syndrome	0.000492	0.143	CbGeAlD
Etravirine—ABCB4—vagina—acquired immunodeficiency syndrome	0.000456	0.132	CbGeAlD
Etravirine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000317	0.0919	CbGeAlD
Etravirine—ABCB4—lymph node—acquired immunodeficiency syndrome	0.000295	0.0856	CbGeAlD
Etravirine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000245	0.0713	CbGeAlD
Etravirine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000187	0.0543	CbGeAlD
Etravirine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000132	0.0385	CbGeAlD
Etravirine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000122	0.0353	CbGeAlD
Etravirine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000116	0.0337	CbGeAlD
Etravirine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000108	0.0312	CbGeAlD
Etravirine—CYP2C9—digestive system—acquired immunodeficiency syndrome	9.44e-05	0.0274	CbGeAlD
Etravirine—CYP2C9—blood—acquired immunodeficiency syndrome	8.99e-05	0.0261	CbGeAlD
Etravirine—ABCB1—retina—acquired immunodeficiency syndrome	7.26e-05	0.0211	CbGeAlD
Etravirine—CYP3A4—digestive system—acquired immunodeficiency syndrome	7.2e-05	0.0209	CbGeAlD
Etravirine—CYP3A4—blood—acquired immunodeficiency syndrome	6.86e-05	0.0199	CbGeAlD
Etravirine—CYP3A4—nervous system—acquired immunodeficiency syndrome	5.57e-05	0.0162	CbGeAlD
Etravirine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	5.36e-05	0.0156	CbGeAlD
Etravirine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	5.16e-05	0.015	CbGeAlD
Etravirine—ABCB1—digestive system—acquired immunodeficiency syndrome	5.09e-05	0.0148	CbGeAlD
Etravirine—ABCB1—blood—acquired immunodeficiency syndrome	4.85e-05	0.0141	CbGeAlD
Etravirine—ABCB1—bone marrow—acquired immunodeficiency syndrome	4.7e-05	0.0136	CbGeAlD
Etravirine—ABCB1—spinal cord—acquired immunodeficiency syndrome	4.68e-05	0.0136	CbGeAlD
Etravirine—ABCB1—vagina—acquired immunodeficiency syndrome	4.5e-05	0.0131	CbGeAlD
Etravirine—ABCB1—lung—acquired immunodeficiency syndrome	4.25e-05	0.0124	CbGeAlD
Etravirine—ABCB1—nervous system—acquired immunodeficiency syndrome	3.94e-05	0.0114	CbGeAlD
Etravirine—ABCB1—central nervous system—acquired immunodeficiency syndrome	3.79e-05	0.011	CbGeAlD
Etravirine—Tremor—Saquinavir—acquired immunodeficiency syndrome	3.48e-05	0.000366	CcSEcCtD
Etravirine—Tension—Lamivudine—acquired immunodeficiency syndrome	3.48e-05	0.000366	CcSEcCtD
Etravirine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	3.48e-05	0.000365	CcSEcCtD
Etravirine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	3.47e-05	0.000364	CcSEcCtD
Etravirine—Constipation—Zidovudine—acquired immunodeficiency syndrome	3.46e-05	0.000364	CcSEcCtD
Etravirine—Pain—Zidovudine—acquired immunodeficiency syndrome	3.46e-05	0.000364	CcSEcCtD
Etravirine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	3.46e-05	0.000364	CcSEcCtD
Etravirine—Syncope—Ritonavir—acquired immunodeficiency syndrome	3.46e-05	0.000364	CcSEcCtD
Etravirine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	3.46e-05	0.000363	CcSEcCtD
Etravirine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	3.45e-05	0.000362	CcSEcCtD
Etravirine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	3.45e-05	0.000362	CcSEcCtD
Etravirine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	3.44e-05	0.000362	CcSEcCtD
Etravirine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	3.44e-05	0.000362	CcSEcCtD
Etravirine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	3.43e-05	0.000361	CcSEcCtD
Etravirine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	3.43e-05	0.000361	CcSEcCtD
Etravirine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	3.43e-05	0.000361	CcSEcCtD
Etravirine—Vomiting—Didanosine—acquired immunodeficiency syndrome	3.41e-05	0.000359	CcSEcCtD
Etravirine—Insomnia—Indinavir—acquired immunodeficiency syndrome	3.41e-05	0.000358	CcSEcCtD
Etravirine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	3.39e-05	0.000357	CcSEcCtD
Etravirine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	3.39e-05	0.000357	CcSEcCtD
Etravirine—Rash—Didanosine—acquired immunodeficiency syndrome	3.39e-05	0.000356	CcSEcCtD
Etravirine—Infection—Delavirdine—acquired immunodeficiency syndrome	3.38e-05	0.000356	CcSEcCtD
Etravirine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	3.38e-05	0.000356	CcSEcCtD
Etravirine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	3.38e-05	0.000356	CcSEcCtD
Etravirine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	3.38e-05	0.000356	CcSEcCtD
Etravirine—Headache—Didanosine—acquired immunodeficiency syndrome	3.36e-05	0.000354	CcSEcCtD
Etravirine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	3.35e-05	0.000353	CcSEcCtD
Etravirine—Shock—Delavirdine—acquired immunodeficiency syndrome	3.35e-05	0.000352	CcSEcCtD
Etravirine—Malaise—Saquinavir—acquired immunodeficiency syndrome	3.35e-05	0.000352	CcSEcCtD
Etravirine—Somnolence—Indinavir—acquired immunodeficiency syndrome	3.35e-05	0.000352	CcSEcCtD
Etravirine—Asthenia—Stavudine—acquired immunodeficiency syndrome	3.34e-05	0.000352	CcSEcCtD
Etravirine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	3.34e-05	0.000351	CcSEcCtD
Etravirine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	3.34e-05	0.000351	CcSEcCtD
Etravirine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	3.34e-05	0.000351	CcSEcCtD
Etravirine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	3.34e-05	0.000351	CcSEcCtD
Etravirine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.00035	CcSEcCtD
Etravirine—Syncope—Saquinavir—acquired immunodeficiency syndrome	3.33e-05	0.00035	CcSEcCtD
Etravirine—Tremor—Lamivudine—acquired immunodeficiency syndrome	3.32e-05	0.000349	CcSEcCtD
Etravirine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	3.31e-05	0.000348	CcSEcCtD
Etravirine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	3.31e-05	0.000348	CcSEcCtD
Etravirine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	3.3e-05	0.000347	CcSEcCtD
Etravirine—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.29e-05	0.000346	CcSEcCtD
Etravirine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	3.29e-05	0.000346	CcSEcCtD
Etravirine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	3.29e-05	0.000346	CcSEcCtD
Etravirine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.28e-05	0.000344	CcSEcCtD
Etravirine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.28e-05	0.000344	CcSEcCtD
Etravirine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	3.27e-05	0.000344	CcSEcCtD
Etravirine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000343	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.26e-05	0.000343	CcSEcCtD
Etravirine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.25e-05	0.000342	CcSEcCtD
Etravirine—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.25e-05	0.000341	CcSEcCtD
Etravirine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.25e-05	0.000341	CcSEcCtD
Etravirine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.25e-05	0.000341	CcSEcCtD
Etravirine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.00034	CcSEcCtD
Etravirine—Constipation—Indinavir—acquired immunodeficiency syndrome	3.22e-05	0.000339	CcSEcCtD
Etravirine—Pain—Indinavir—acquired immunodeficiency syndrome	3.22e-05	0.000339	CcSEcCtD
Etravirine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.22e-05	0.000338	CcSEcCtD
Etravirine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	3.22e-05	0.000338	CcSEcCtD
Etravirine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.21e-05	0.000338	CcSEcCtD
Etravirine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000337	CcSEcCtD
Etravirine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.2e-05	0.000337	CcSEcCtD
Etravirine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.2e-05	0.000337	CcSEcCtD
Etravirine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.2e-05	0.000336	CcSEcCtD
Etravirine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.2e-05	0.000336	CcSEcCtD
Etravirine—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.2e-05	0.000336	CcSEcCtD
Etravirine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.19e-05	0.000335	CcSEcCtD
Etravirine—Nausea—Didanosine—acquired immunodeficiency syndrome	3.19e-05	0.000335	CcSEcCtD
Etravirine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.18e-05	0.000335	CcSEcCtD
Etravirine—Syncope—Lamivudine—acquired immunodeficiency syndrome	3.18e-05	0.000334	CcSEcCtD
Etravirine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	3.18e-05	0.000334	CcSEcCtD
Etravirine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.17e-05	0.000333	CcSEcCtD
Etravirine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	3.15e-05	0.000331	CcSEcCtD
Etravirine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.14e-05	0.00033	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.14e-05	0.00033	CcSEcCtD
Etravirine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.12e-05	0.000328	CcSEcCtD
Etravirine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	3.11e-05	0.000327	CcSEcCtD
Etravirine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.11e-05	0.000326	CcSEcCtD
Etravirine—Shock—Ritonavir—acquired immunodeficiency syndrome	3.1e-05	0.000326	CcSEcCtD
Etravirine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.09e-05	0.000325	CcSEcCtD
Etravirine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.09e-05	0.000325	CcSEcCtD
Etravirine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.09e-05	0.000325	CcSEcCtD
Etravirine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.09e-05	0.000325	CcSEcCtD
Etravirine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.000324	CcSEcCtD
Etravirine—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.08e-05	0.000324	CcSEcCtD
Etravirine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.08e-05	0.000324	CcSEcCtD
Etravirine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.08e-05	0.000324	CcSEcCtD
Etravirine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.07e-05	0.000323	CcSEcCtD
Etravirine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	3.07e-05	0.000323	CcSEcCtD
Etravirine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.07e-05	0.000323	CcSEcCtD
Etravirine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.07e-05	0.000323	CcSEcCtD
Etravirine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.06e-05	0.000322	CcSEcCtD
Etravirine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.06e-05	0.000321	CcSEcCtD
Etravirine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.06e-05	0.000321	CcSEcCtD
Etravirine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.05e-05	0.00032	CcSEcCtD
Etravirine—Pain—Efavirenz—acquired immunodeficiency syndrome	3.04e-05	0.00032	CcSEcCtD
Etravirine—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.04e-05	0.00032	CcSEcCtD
Etravirine—Rash—Nevirapine—acquired immunodeficiency syndrome	3.04e-05	0.00032	CcSEcCtD
Etravirine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.04e-05	0.00032	CcSEcCtD
Etravirine—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.04e-05	0.000319	CcSEcCtD
Etravirine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.03e-05	0.000318	CcSEcCtD
Etravirine—Headache—Nevirapine—acquired immunodeficiency syndrome	3.02e-05	0.000318	CcSEcCtD
Etravirine—Infection—Saquinavir—acquired immunodeficiency syndrome	3.01e-05	0.000317	CcSEcCtD
Etravirine—ABCB1—brain—acquired immunodeficiency syndrome	3.01e-05	0.00874	CbGeAlD
Etravirine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.01e-05	0.000316	CcSEcCtD
Etravirine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3e-05	0.000316	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3e-05	0.000315	CcSEcCtD
Etravirine—Shock—Saquinavir—acquired immunodeficiency syndrome	2.98e-05	0.000314	CcSEcCtD
Etravirine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	2.98e-05	0.000313	CcSEcCtD
Etravirine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	2.98e-05	0.000313	CcSEcCtD
Etravirine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	2.98e-05	0.000313	CcSEcCtD
Etravirine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	2.97e-05	0.000313	CcSEcCtD
Etravirine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	2.97e-05	0.000312	CcSEcCtD
Etravirine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	2.97e-05	0.000312	CcSEcCtD
Etravirine—Vomiting—Stavudine—acquired immunodeficiency syndrome	2.96e-05	0.000312	CcSEcCtD
Etravirine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	2.96e-05	0.000311	CcSEcCtD
Etravirine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	2.95e-05	0.00031	CcSEcCtD
Etravirine—Rash—Nelfinavir—acquired immunodeficiency syndrome	2.95e-05	0.00031	CcSEcCtD
Etravirine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	2.95e-05	0.00031	CcSEcCtD
Etravirine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	2.94e-05	0.00031	CcSEcCtD
Etravirine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	2.94e-05	0.000309	CcSEcCtD
Etravirine—Rash—Stavudine—acquired immunodeficiency syndrome	2.94e-05	0.000309	CcSEcCtD
Etravirine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	2.94e-05	0.000309	CcSEcCtD
Etravirine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	2.94e-05	0.000309	CcSEcCtD
Etravirine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	2.93e-05	0.000308	CcSEcCtD
Etravirine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.93e-05	0.000308	CcSEcCtD
Etravirine—Headache—Nelfinavir—acquired immunodeficiency syndrome	2.93e-05	0.000308	CcSEcCtD
Etravirine—Headache—Stavudine—acquired immunodeficiency syndrome	2.92e-05	0.000307	CcSEcCtD
Etravirine—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.92e-05	0.000307	CcSEcCtD
Etravirine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	2.92e-05	0.000307	CcSEcCtD
Etravirine—Pain—Delavirdine—acquired immunodeficiency syndrome	2.91e-05	0.000306	CcSEcCtD
Etravirine—Constipation—Delavirdine—acquired immunodeficiency syndrome	2.91e-05	0.000306	CcSEcCtD
Etravirine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	2.91e-05	0.000306	CcSEcCtD
Etravirine—ABCB1—lymph node—acquired immunodeficiency syndrome	2.91e-05	0.00845	CbGeAlD
Etravirine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.91e-05	0.000306	CcSEcCtD
Etravirine—Rash—Abacavir—acquired immunodeficiency syndrome	2.9e-05	0.000304	CcSEcCtD
Etravirine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.89e-05	0.000304	CcSEcCtD
Etravirine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.89e-05	0.000304	CcSEcCtD
Etravirine—Headache—Abacavir—acquired immunodeficiency syndrome	2.88e-05	0.000302	CcSEcCtD
Etravirine—Infection—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000302	CcSEcCtD
Etravirine—Nausea—Nevirapine—acquired immunodeficiency syndrome	2.87e-05	0.000301	CcSEcCtD
Etravirine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	2.85e-05	0.000299	CcSEcCtD
Etravirine—Shock—Lamivudine—acquired immunodeficiency syndrome	2.85e-05	0.000299	CcSEcCtD
Etravirine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	2.84e-05	0.000298	CcSEcCtD
Etravirine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000298	CcSEcCtD
Etravirine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.83e-05	0.000297	CcSEcCtD
Etravirine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.81e-05	0.000296	CcSEcCtD
Etravirine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	2.81e-05	0.000296	CcSEcCtD
Etravirine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	2.81e-05	0.000295	CcSEcCtD
Etravirine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	2.81e-05	0.000295	CcSEcCtD
Etravirine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	2.8e-05	0.000294	CcSEcCtD
Etravirine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	2.8e-05	0.000294	CcSEcCtD
Etravirine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.79e-05	0.000293	CcSEcCtD
Etravirine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.78e-05	0.000292	CcSEcCtD
Etravirine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.78e-05	0.000292	CcSEcCtD
Etravirine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.77e-05	0.000291	CcSEcCtD
Etravirine—Nausea—Stavudine—acquired immunodeficiency syndrome	2.77e-05	0.000291	CcSEcCtD
Etravirine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.76e-05	0.00029	CcSEcCtD
Etravirine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.000288	CcSEcCtD
Etravirine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.74e-05	0.000288	CcSEcCtD
Etravirine—Nausea—Abacavir—acquired immunodeficiency syndrome	2.73e-05	0.000287	CcSEcCtD
Etravirine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	2.72e-05	0.000286	CcSEcCtD
Etravirine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	2.72e-05	0.000286	CcSEcCtD
Etravirine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	2.72e-05	0.000285	CcSEcCtD
Etravirine—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.7e-05	0.000284	CcSEcCtD
Etravirine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	2.7e-05	0.000283	CcSEcCtD
Etravirine—Pain—Ritonavir—acquired immunodeficiency syndrome	2.69e-05	0.000283	CcSEcCtD
Etravirine—Constipation—Ritonavir—acquired immunodeficiency syndrome	2.69e-05	0.000283	CcSEcCtD
Etravirine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	2.69e-05	0.000283	CcSEcCtD
Etravirine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.69e-05	0.000283	CcSEcCtD
Etravirine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	2.68e-05	0.000282	CcSEcCtD
Etravirine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.64e-05	0.000277	CcSEcCtD
Etravirine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.62e-05	0.000276	CcSEcCtD
Etravirine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.62e-05	0.000275	CcSEcCtD
Etravirine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	2.62e-05	0.000275	CcSEcCtD
Etravirine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.61e-05	0.000275	CcSEcCtD
Etravirine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.6e-05	0.000273	CcSEcCtD
Etravirine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.6e-05	0.000273	CcSEcCtD
Etravirine—Pain—Saquinavir—acquired immunodeficiency syndrome	2.59e-05	0.000273	CcSEcCtD
Etravirine—Constipation—Saquinavir—acquired immunodeficiency syndrome	2.59e-05	0.000273	CcSEcCtD
Etravirine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.58e-05	0.000271	CcSEcCtD
Etravirine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.58e-05	0.000271	CcSEcCtD
Etravirine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.58e-05	0.000271	CcSEcCtD
Etravirine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.57e-05	0.00027	CcSEcCtD
Etravirine—Rash—Zidovudine—acquired immunodeficiency syndrome	2.55e-05	0.000269	CcSEcCtD
Etravirine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.55e-05	0.000268	CcSEcCtD
Etravirine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.55e-05	0.000268	CcSEcCtD
Etravirine—Headache—Zidovudine—acquired immunodeficiency syndrome	2.54e-05	0.000267	CcSEcCtD
Etravirine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.51e-05	0.000264	CcSEcCtD
Etravirine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.51e-05	0.000264	CcSEcCtD
Etravirine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.5e-05	0.000263	CcSEcCtD
Etravirine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.5e-05	0.000262	CcSEcCtD
Etravirine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.49e-05	0.000262	CcSEcCtD
Etravirine—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.49e-05	0.000262	CcSEcCtD
Etravirine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.49e-05	0.000262	CcSEcCtD
Etravirine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.49e-05	0.000262	CcSEcCtD
Etravirine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.48e-05	0.000261	CcSEcCtD
Etravirine—Constipation—Lamivudine—acquired immunodeficiency syndrome	2.47e-05	0.00026	CcSEcCtD
Etravirine—Pain—Lamivudine—acquired immunodeficiency syndrome	2.47e-05	0.00026	CcSEcCtD
Etravirine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.44e-05	0.000257	CcSEcCtD
Etravirine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.44e-05	0.000256	CcSEcCtD
Etravirine—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.41e-05	0.000253	CcSEcCtD
Etravirine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.4e-05	0.000252	CcSEcCtD
Etravirine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.4e-05	0.000252	CcSEcCtD
Etravirine—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.4e-05	0.000252	CcSEcCtD
Etravirine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.38e-05	0.000251	CcSEcCtD
Etravirine—Rash—Indinavir—acquired immunodeficiency syndrome	2.38e-05	0.00025	CcSEcCtD
Etravirine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.37e-05	0.000249	CcSEcCtD
Etravirine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.37e-05	0.000249	CcSEcCtD
Etravirine—Headache—Indinavir—acquired immunodeficiency syndrome	2.36e-05	0.000248	CcSEcCtD
Etravirine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.35e-05	0.000247	CcSEcCtD
Etravirine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.33e-05	0.000245	CcSEcCtD
Etravirine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.32e-05	0.000244	CcSEcCtD
Etravirine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.29e-05	0.00024	CcSEcCtD
Etravirine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.29e-05	0.00024	CcSEcCtD
Etravirine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.26e-05	0.000238	CcSEcCtD
Etravirine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.26e-05	0.000238	CcSEcCtD
Etravirine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.25e-05	0.000237	CcSEcCtD
Etravirine—Rash—Efavirenz—acquired immunodeficiency syndrome	2.24e-05	0.000236	CcSEcCtD
Etravirine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.24e-05	0.000236	CcSEcCtD
Etravirine—Nausea—Indinavir—acquired immunodeficiency syndrome	2.24e-05	0.000235	CcSEcCtD
Etravirine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.23e-05	0.000235	CcSEcCtD
Etravirine—Headache—Efavirenz—acquired immunodeficiency syndrome	2.23e-05	0.000234	CcSEcCtD
Etravirine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.18e-05	0.000229	CcSEcCtD
Etravirine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.17e-05	0.000228	CcSEcCtD
Etravirine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.16e-05	0.000227	CcSEcCtD
Etravirine—Rash—Delavirdine—acquired immunodeficiency syndrome	2.15e-05	0.000226	CcSEcCtD
Etravirine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.15e-05	0.000226	CcSEcCtD
Etravirine—Headache—Delavirdine—acquired immunodeficiency syndrome	2.13e-05	0.000224	CcSEcCtD
Etravirine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.13e-05	0.000224	CcSEcCtD
Etravirine—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.11e-05	0.000222	CcSEcCtD
Etravirine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.08e-05	0.000219	CcSEcCtD
Etravirine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.08e-05	0.000218	CcSEcCtD
Etravirine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.07e-05	0.000218	CcSEcCtD
Etravirine—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.02e-05	0.000213	CcSEcCtD
Etravirine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2e-05	0.000211	CcSEcCtD
Etravirine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2e-05	0.000211	CcSEcCtD
Etravirine—Rash—Ritonavir—acquired immunodeficiency syndrome	1.99e-05	0.000209	CcSEcCtD
Etravirine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.000209	CcSEcCtD
Etravirine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	1.98e-05	0.000208	CcSEcCtD
Etravirine—Headache—Ritonavir—acquired immunodeficiency syndrome	1.97e-05	0.000207	CcSEcCtD
Etravirine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.93e-05	0.000203	CcSEcCtD
Etravirine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.91e-05	0.000201	CcSEcCtD
Etravirine—Rash—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000201	CcSEcCtD
Etravirine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000201	CcSEcCtD
Etravirine—Headache—Saquinavir—acquired immunodeficiency syndrome	1.9e-05	0.0002	CcSEcCtD
Etravirine—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.87e-05	0.000197	CcSEcCtD
Etravirine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.84e-05	0.000193	CcSEcCtD
Etravirine—Rash—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000192	CcSEcCtD
Etravirine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000192	CcSEcCtD
Etravirine—Headache—Lamivudine—acquired immunodeficiency syndrome	1.81e-05	0.00019	CcSEcCtD
Etravirine—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.8e-05	0.000189	CcSEcCtD
Etravirine—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.72e-05	0.000181	CcSEcCtD
